氧化应激在碘海醇诱导人肾小管上皮细胞凋亡中的作用

被引:8
作者
戴宁
吴华
李天慧
赵班
陈欢
李湛
机构
[1] 卫生部北京医院肾内科
关键词
人肾小管上皮细胞; 凋亡; 活性氧; N-乙酰半胱氨酸;
D O I
10.15932/j.0253-9713.2010.05.023
中图分类号
R692 [肾疾病];
学科分类号
100221 [泌尿外科学];
摘要
目的观察碘海醇诱导的人肾小管上皮细胞(HK-2)凋亡及氧化应激所起的作用。方法将体外培养的HK-2细胞分为4组:①对照组;②碘海醇组(100mgI/ml);③N-乙酰半胱氨酸(NAC 10mmol/L)组;④共作用组:NAC10mmol/L预处理1h+碘海醇100mgI/ml。各组以相应药物孵育6h。采用细胞增殖/毒性检测法(CCK-8)测定细胞存活率,核染色、流式Annexin Ⅴ-FITC/PI双染法检测细胞凋亡,DCFH-DA荧光结合流式细胞法检测细胞内活性氧(ROS)的产生,IF、Western blot检测相关信号转导途径。结果碘海醇降低HK-2细胞存活率至(63±5%)(P<0.01),细胞凋亡率升至24.41%(对照组0.9%,P<0.05),细胞内活性氧升高至对照组的1.3倍(P<0.05)。NAC预处理与碘海醇共作用后,HK-2细胞存活率比碘海醇组明显增高(118%vs.63%,P<0.05),凋亡率比碘海醇组明显降低(13.46%vs.24.41%,P<0.05),活性氧降为对照组的0.93倍,比碘海醇组(1.3倍)明显降低(P<0.05)。碘海醇作用于HK-2细胞,引起p53磷酸化,上调凋亡相关蛋白(Bax),下调Bcl-2的表达,促进线粒体内细胞色素C(CytC)释放到胞质,进而引起Caspase-3活化,导致细胞凋亡。NAC降低细胞内活性氧浓度,下调Bax、上调Bcl-2、减少Caspase-3活化,从而减轻细胞损伤。结论碘海醇引起的氧化应激在其诱导的HK-2细胞凋亡中起重要作用。
引用
收藏
页码:396 / 399
页数:4
相关论文
共 6 条
[1]
Serofendic acid protects from iodinated contrast medium and high glucose probably against superoxide production in LLC-PK1 cells [J].
Kitamura, Osamu ;
Uemura, Kazuhide ;
Kitamura, Hisayo ;
Sugimoto, Hachiro ;
Akaike, Akinori ;
Ono, Takahiko .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2009, 13 (01) :15-24
[2]
One-year mortality in critically ill patients by severity of kidney dysfunction: A population-based assessment [J].
Bagshaw, Sean M. ;
Mortis, Garth ;
Doig, Christopher J. ;
Godinez-Luna, Tomas ;
Fick, Gordon H. ;
Laupland, Kevin B. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (03) :402-409
[3]
Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention [J].
Spargias, K ;
Alexopoulos, E ;
Kyrzopoulos, S ;
Iacovis, P ;
Greenwood, DC ;
Manginas, A ;
Voudris, V ;
Pavlides, G ;
Buller, CE ;
Kremastinos, D ;
Cokkinos, DV .
CIRCULATION, 2004, 110 (18) :2837-2842
[4]
Cell Death.[J].Nika N Danial;Stanley J Korsmeyer.Cell.2004, 2
[5]
Flavone inhibition of tumor growth via apoptosis in vitro and in vivo [J].
Chen, YC ;
Shen, SC ;
Chow, JM ;
Ko, CH ;
Tseng, SW .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (03) :661-670
[6]
Hospital-acquired renal insufficiency [J].
Nash, K ;
Hafeez, A ;
Hou, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) :930-936